Arthritic Therapeutic Market
The global arthritic therapeutic market is experiencing remarkable growth, fueled by an aging population, rising arthritis prevalence, and advancements in biologic and biosimilar therapies. In 2022, the market was valued at $79.5 billion and is projected to reach $136.1 billion by 2032, expanding at a CAGR of 5.5% from 2023 to 2032. As demand for innovative treatments increases, stakeholders must navigate key drivers, challenges, and opportunities to remain competitive in this evolving landscape.
Comments
Post a Comment